Introduction
============

Asthma is a very common childhood condition worldwide and in Hong Kong. Acute asthmatic attacks cause significant morbidity and account for a significant number of emergency department consultations and hospital admissions\[[@B1]-[@B4]\]. Most children admitted to the hospital because of acute asthma do not require intensive care treatment. Nevertheless, a small percentage of children with life-threatening asthma (LTA) would develop progressive respiratory failure refractory to treatment and require admission to the pediatric intensive care unit (PICU)\[[@B5]-[@B7]\]. In those who are admitted to the ICU, approximately 10 to 33% need intubation and mechanical ventilation, with a risk of worsening bronchospasm and hyperinflation, barotrauma, and cardiovascular depression\[[@B8],[@B9]\]. If not promptly managed, severe asthmatic attacks may occasionally result in death\[[@B1]-[@B10]\]. The purpose of this study was to report the clinical pattern and outcome of all children with LTA and severe bronchospasm admitted to the PICU.

Methods
=======

We retrospectively reviewed the medical records and analyzed data from all children with LTA admitted to the PICU of a tertiary care university hospital (Prince of Wales Hospital) in Hong Kong during the period October 2002 and May 2010. LTA was defined as all children with asthma who required ICU admission and care. The initial diagnosis was made clinically by the admitting physicians. Final diagnosis was confirmed on chart review and subsequent evaluations. The hospital provides PICU care to a catchment population of approximately 1.1 million. The following data were collected: age, sex, duration of admission, treatment of the LTA, clinical condition, blood gases, the incidence of barotrauma, and outcome. Respiratory viruses and bacterial pathogens were routinely screened for by standard examination of nasopharyngeal aspirate and cultures. The Pediatric Index of Mortality 2 (PIM2) score based on admission data was used as severity score\[[@B11]\]. Numerical data were compared with Mann Whitney U test and categorical data with χ^2^or Fisher exact test. All comparisons were made two-tailed, and p-values less than 0.05 considered statistically significant.

Results
=======

There were 30 admissions (13 boys and 17 girls; median age, 3.1 years; IQR 2.0 - 6.8 years; Table [1](#T1){ref-type="table"}) with LTA which accounted for 3% of total PICU admissions (n = 1033) over a study period of 7 years and 8 months. Two male patients were admitted twice because of a recurrent episode of LTA. Indications for admission to the PICU were severe dyspnea, worsening or failure to improve on nebulized bronchodilators, and need for administration of intravenous salbutamol or mechanical ventilation. The decision for PICU admission was determined clinically together with blood gas as well as pulse oximetry parameters by the admitting physicians.

###### 

Clinical data of children with status asthmaticus admitted to PICU

  -------------------------------------------------------------------------------------------------------------------------------------------------------------
  Case                                                                                       Total\             Ventilated\        Non-ventilated\   P\*
                                                                                             (n = 30)           (n = 6)            (n = 24)          
  ------------------------------------------------------------------------------------------ ------------------ ------------------ ----------------- ----------
  Male (%)                                                                                   13 (0)             5 (75)             8 (40)            0.06

  Median age (IQR), yr                                                                       3.1 (2.0-5.4)      3.3 (2.0-5.5)      3.1 (1.9-6.8)     0.84

  Median (IQR) PIM2, %                                                                       0.50 (0.30-1.00)   1.65 (1.45-1.95)   0.4 (0.3-0.5)     \< 0.001

  **Relevant risk factors**                                                                                                                          

  Family history of atopy                                                                    12                 1                  11                0.36

  Prematurity \< 36 weeks (%)                                                                4 (14)             0 (12)             4 (15)            0.57

  History of chronic lung disease, bronchiolitis, pneumonia, or pneumothorax (%)             7 (17)             0 (0)              7 (25)            0.29

  Neurodevelopmental delay (mental retardation, cerebral palsy, neuromuscular disease) (%)   2 (14)             0 (25)             2 (10)            1.00

  Previous asthma admission (%)                                                              16 (50)            4 (62)             12 (45)           0.66

  Maintenance inhaled CS (%)                                                                 12 (35)            3 (37)             9 (35)            0.66

  Non-compliance (%)                                                                         7 (25)             2 (25)             5 (25)            0.60

  1^st^PaCO~2~in PICU, kPa                                                                   5.5 (4.3-7.9)      9.3 (6.4-10.9)     5.1 (4.3-5.9)     0.01

  1^st^PaO~2~in PICU, kPa                                                                    9.9 (7.8-13.2)     10.1 (9.4-13.5)    9.3 (7.5-13.3)    0.40

  Viral isolation (%)                                                                        2 (3)              0 (0)              2 (5)             1.00

  **Treatment at PICU**                                                                                                                              

  Systemic CS (%)                                                                            30 (100)           6 (100)            24 (100)          N/A

  Inhaled salbutamol (%)                                                                     22 (73)            5 (83)             17 (71)           1.00

  Inhaled ipratropium (%)                                                                    7 (23)             0 (0)              7 (29)            0.29

  Inhaled adrenaline (%)                                                                     2 (7)              1 (17)             1 (4)             0.37

  Intravenous salbutamol (%)                                                                 22 (73)            5 (83)             17 (71)           1.00

  Intravenous magnesium sulphate (%)                                                         4 (13)             2 (33)             2 (8)             0.17

  Systemic antibiotics (%)                                                                   19 (63)            5 (83)             14 (58)           0.37

  **Outcome**                                                                                                                                        

  Median (IQR) PICU stay, day                                                                2.0 (1.0-2.5)      2.5 (2.0-4.5)      2.0 (1.0-2.0)     0.03

  Median (IQR) hospital stay, day                                                            5.0 (3.0-7.5)      6.5 (3.0-20.0)     5.0 (3.0-6.8)     0.27

  Pneumothorax (%)                                                                           1 (3)              0 (0)              1 (4)             1.00

  Died in PICU                                                                               0                  0                  0                 N/A
  -------------------------------------------------------------------------------------------------------------------------------------------------------------

CS: corticosteroid; IQR, interquartile range; N/A, not applicable.

\* Analyzed between ventilated and non-ventilated patients by Fisher exact test or Pearson χ^2^for categorical variables and Mann-Whitney U test for numerical variables.

In terms of risk factors, \'smoker(s) at home\' were present in 5 of the admissions, \'history of atopy in 1 st degree relative\' in 11 admissions, and \'personal history of atopy\' in 20 admissions. Few had past history of prematurity (n = 4 admissions), lung diseases (1 neonatal pneumothorax, 1 pneumonia, 1 chronic lung disease, and 4 recurrent bronchiolitis), neuro-developmental condition (Rasmussen\'s encephalitis plus epilepsy × 2 admissions). Half had previous admissions for asthma and one-fourth with history of non-compliance to recommended treatment for asthma. In the ventilated group, three patients were on inhaled corticosteroid but compliance to corticosteroid was reportedly poor in two. In the non-ventilated group, 9 patients were on inhaled corticosteroid. One patient also received oral montelukast. Poor-compliance to asthma management was reported in 5 patients. One patient had parainfluenza virus and one had rhinovirus isolated. None of these factors were associated with need for mechanical ventilation which was required in 6 patients. Ventilator modes included Synchronized Intermittent Mandatory Ventilation (SIMV) or Pressure Regulated Volume Control mode (PRVC), with low Positive End-Expiratory Pressure (PEEP) and low inspiratory to expiratory (I:E) ratios. Comparing with patients who did not receive mechanical ventilation, ventilated children had significantly higher PIM2 score (1.65 versus 0.4, p \< 0.001), higher first PaCO~2~levels measured at PICU (9.3 kPa versus 5.1 kpa, p = 0.01) and longer PICU stay (median 2.5 days versus 2 days, *p*= 0.03) but no differences in other factors evaluated in Table [1](#T1){ref-type="table"}. These patients received systemic corticosteroids and intravenous or inhaled bronchodilators. Some received intravenous magnesium sulphate. There was one pneumothorax but no death in this series. A 7-year-old girl with asthma but no previous asthma hospitalization, presented with sudden dyspnoea following a 2-day history of blocked nose and cough. Her private practitioner prescribed inhaled and oral bronchodilators. However, dyspnoea was not relieved and chest radiograph at the emergency department revealed left apical pneumothorax, which was drained with a chest drain. CT scan of the thorax showed subcutaneous emphysema, pneumomediastinum, and pneumothorax. Her symptoms resolved at the PICU following corticosteroid and inhaled salbutamol. Mechanical ventilation was not required. The chest drain was removed three days later. Regardless of mechanical ventilation, all had very brief PICU stays (median 2 days; range, 1 to 7 days). Furthermore, there did not appear to be any increase in incidence of PICU admissions for LTA between 2003-2009 (median 2% of PICU admissions; Table [2](#T2){ref-type="table"}).

###### 

The incidence of PICU admissions for LTA during the study period

  Year                  PICU admissions   PICU for LTA (%)
  --------------------- ----------------- ------------------
  2002 (partial data)   33                1 (3)
  2003                  122               7 (6)
  2004                  155               3 (2)
  2005                  111               2 (2)
  2006                  127               3 (2)
  2007                  144               5 (3)
  2008                  138               3 (2)
  2009                  140               3 (2)
  2010 (partial data)   63                3 (5)

Median of 2% of annual PICU admissions were due to LTA (average absolute deviation from Median = 1.0%)

Discussion
==========

Incidence of PICU admissions
----------------------------

Asthma is a common disease and its frequency of occurrence sometimes detracts from its potential seriousness\[[@B12]\]. Severe asthma in children is a frequent cause of hospital and pediatric ICU admissions in reported series\[[@B12]-[@B14]\]. Globally, morbidity and mortality associated with asthma have increased over the last 2 decades\[[@B1],[@B2],[@B4]\]. This increase is attributed to increasing urbanization and undertreatment of asthma especially among the high risk pediatric population with low-socio-economic class\[[@B15]\]. Despite advancements in our understanding of asthma and the development of new therapeutic strategies, the morbidity and mortality rates due to asthma reportedly increased between 1980 and 1995\[[@B2],[@B4],[@B13]\]. In the United States, the mortality rate due to asthma has increased in all age, race, and sex strata. From 1975-1993, the number of deaths nearly doubled in people aged 5-14 years\[[@B2]\]. In Hong Kong, data about severe asthma hospitalizations are lacking. In a previous study, we reported that asthma accounts for approximately 10% of general pediatric admissions\[[@B3]\]. In the present study, the admission rate was only 3% of PICU admissions. It appears that LTA is a relative uncommon cause of PICU admission in our locality. The reason for this is unknown. It might reflect that treatment received at the emergency department is prompt and effective to halt PICU admission\[[@B6]\].

PICU treatment
--------------

Status asthmaticus is severe asthma that does not respond well to immediate care and is a life-threatening medical emergency\[[@B5]\]. Ensuing respiratory failure results in hypoxia, carbon dioxide retention and acidosis\[[@B16]\]. Patients require aggressive treatment with oxygen, bronchodilators, and corticosteroids\[[@B5],[@B17]-[@B19]\]. Rapid reversal of airflow obstruction is achieved by using repeated or continuous administration of an inhaled beta2-agonist. Early administration of systemic corticosteroids (oral or intravenous) is indicated in children with LTA\[[@B5],[@B19]\]. In severe cases, alveolar hypoventilation requires mechanically assisted ventilation\[[@B1],[@B5],[@B8],[@B16]\]. In our study, the only significant difference between ventilated and non-ventilated group is the presence of CO~2~retention. LTA can be associated with metabolic acidosis, which reduces the effectiveness of ß-agonists\[[@B9]\]. In a prospective randomized trial, continuous nebulization of albuterol is safe and results in more rapid clinical improvement than intermittent nebulization in children with impending respiratory failure due to status asthmaticus\[[@B20]\]. In severe LTA attacks, intravenous salbutamol was found to be a safe and effective bronchodilator capable of reversing severe bronchospasm in most children who would otherwise require mechanical ventilation\[[@B21]\]. Mechanical ventilation compromises active expiration with increased air trapping and hypercapnia, and should therefore be delayed as long as possible by using medical therapy\[[@B1]\]. Noninvasive positive pressure has also been advocated but further evaluation of its efficacy is required\[[@B22]\].

Co-infections
-------------

One of the clinical problems facing pediatric intensivists is the differentiation between viral and bacterial infections when an acutely ill child with LTA is admitted. Empirical course of antibiotics were often used in the initial management in order to avoid missing any treatable bacterial co-infections. Rapid diagnosis of respiratory viral infections in children is important because prompt diagnosis may result in significantly reduced antibiotic use and unnecessary strict isolation for respiratory viruses. In this study, there was no bacterial isolation and viral co-infection was only found in two cases (parainfluenza and rhinovirus).

Complications and morbidity
---------------------------

Status asthmaticus is one of the most common causes of admission to a pediatric intensive care unit (PICU). There have been published data examining the complications associated with the treatment of status asthmaticus in children in the PICU. In one study of children admitted to PICU, there was a 22% complication rate, increased by intubation\[[@B14]\]. The risk of death is increased where there is delay in getting treatment, particularly time to starting steroids. Another retrospective review showed 8% of children admitted to the ICU with status asthmaticus experienced one or more complications during their treatment. The most common complications were aspiration pneumonia, ventilator-associated pneumonia, pneumomediastinum, pneumothorax, and rhabdomyolysis\[[@B23]\]. Intubated children were significantly more likely than non-intubated children to experience a complication (RR 15.3; 95% CI 6.7-35). Intubated children experiencing a complication also had significantly longer duration of mechanical ventilation, ICU length of stay, and hospital charges than intubated children not experiencing a complication, suggesting that intubation and mechanical ventilation itself may increase the risk of developing a complication in this population\[[@B7],[@B14]\]. Asthma patients have variable resolution of airway obstruction during mechanical ventilation and controlled hypoventilation can be a safe therapy for the patients with more severe obstruction\[[@B8]\]. Prompt treatment with corticosteroid, bronchodilator (intravenous route if needed), magnesium sulphate, permissive hypercarbia, and the avoidance of mechanic ventilation together might have accounted for the satisfactory outcome seen in our patients. Indeed mechanical ventilation has not been needed for the past 3 years in our unit.

Near-fatal asthma continues to be a significant problem despite the decline in overall asthma mortality. Two distinctive phenotypes of near-fatal asthma have been identified: one with eosinophilic inflammation associated with a gradual onset and a slow response to therapy and a second phenotype with neutrophilic inflammation that has a rapid onset and rapid response to therapy. In stable condition, near-fatal asthma frequently cannot be distinguished from mild asthma. Diminished perception of dyspnea plays a relevant role in treatment delay, near-fatal events, and death in patients with severe asthma. Reduced compliance with anti-inflammatory therapy has also been associated with fatal or near-fatal asthma\[[@B24]\]. The sudden-onset patients were older and they more commonly presented to the emergency department between midnight and 8:00 am with severe exacerbations that required intubation and intensive care unit admission. Nevertheless, this sudden-onset group was discharged from the hospital earlier\[[@B25]\]. The preventable factors included inadequate assessment or therapy of prior asthma, poor compliance with therapy, and delay in seeking help\[[@B10]\]. In our series, history of previous asthma admissions and noncompliance were also relevant factors. Nevertheless, we report no fatality and the majority required brief PICU stay regardless of need for mechanical ventilation.

Approximately one third of patients were on maintenance inhaled corticosteroid; many of these patients were on inhaled salbutamol on a *prn-*basis and had been asymptomatic for a number of months, but some were non-compliant to prescribed therapy. The limitation of this study is the small sample size and there was high chance of type II error with regard to different parameters studied.

In conclusion, LTA and bronchospasm accounted for a small percentage of PICU admissions following initial stabilization at the emergency department. Approximately 20% required ventilatory supports. Ventilated patients appeared to have higher PIM2 severity score, higher PCO~2~and longer PICU stays. Regardless of the need for mechanical ventilation, all patients survived with prompt treatment, and only required brief PICU stays.
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